Refractory status epilepticus (ICU)
status epilepticus · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Status epilepticus that continues despite adequate benzodiazepine and a second-line antiseizure medication is refractory and requires intubation and anaesthetic (third-line) infusions titrated to seizure control or burst suppression. Super-refractory status persists beyond 24 h of anaesthesia and needs aggressive investigation for the underlying cause.
Red flags
- Ongoing electrographic seizures despite two agents
- Falling conscious level without motor signs (non-convulsive status)
- Hyperthermia and rhabdomyolysis
- Hypotension from anaesthetic infusions
- Metabolic acidosis on high-dose propofol (PRIS)
Assessment
Differential diagnosis
- CNS infection (encephalitis/meningitis)
- Acute structural lesion (stroke, haemorrhage, tumour)
- Autoimmune encephalitis
- Metabolic derangement (sodium, glucose, calcium)
- Drug toxicity / withdrawal
- Anoxic brain injury
- Non-convulsive status
Investigations
- Capillary and lab glucose, sodium, calcium, magnesium
- Continuous EEG monitoring
- CT/MRI brain
- Lumbar puncture (CNS infection/autoimmune)
- Antiseizure drug levels and toxicology
- Autoimmune and paraneoplastic antibodies
Management
- Confirm ongoing seizures (clinical or electrographic) and secure airway, breathing and circulation
- Check and correct glucose, sodium, calcium and magnesium immediately
- First-line: a benzodiazepine at an adequate dose (lorazepam IV, or IM midazolam if no access)
- Second-line (urgent control) antiseizure medication: levetiracetam, or sodium valproate, or phenytoin/fosphenytoin at full loading dose
- If seizures continue, declare refractory status, intubate and start a third-line anaesthetic infusion (midazolam, propofol or thiopentone)
- Titrate the anaesthetic to seizure cessation, then to electrographic burst suppression on continuous EEG for 24-48 h
- Continue maintenance antiseizure medications alongside the anaesthetic
- Investigate and treat the cause aggressively (empirical aciclovir and antibiotics if CNS infection possible; immunotherapy if autoimmune suspected)
- Maintain haemodynamics and watch for propofol infusion syndrome with high-dose propofol
- Wean the anaesthetic slowly after 24-48 h of control and watch for seizure recurrence on EEG
- For super-refractory status escalate therapies (ketamine, additional agents, immunotherapy, ketogenic diet) with neurology
- Avoid and correct hyperthermia and metabolic complications
Drugs & doses
Lorazepam 0.1 mg/kg IV (max 4 mg/dose, may repeat once)
Midazolam 10 mg IM if no IV access
Levetiracetam 60 mg/kg IV (max 4.5 g)
Sodium valproate 40 mg/kg IV (max 3 g)
Fosphenytoin 20 mg PE/kg IV
Midazolam infusion 0.05-2 mg/kg/h IV
Propofol infusion 1-5 mg/kg/h IV (watch PRIS)
Thiopentone 3-5 mg/kg load then 1-5 mg/kg/h IV
Ketamine infusion for super-refractory cases
Disposition
ICU with continuous EEG and neurology input; consider transfer to a neurocritical care centre for super-refractory status.
Complications & pitfalls
- Neuronal injury and cognitive sequelae
- Aspiration and respiratory failure
- Propofol infusion syndrome
- Haemodynamic instability
- Rhabdomyolysis and AKI
- Death
Exam pearls
- Underdosing benzodiazepines is the commonest early error - give the full weight-based dose
- Any unexplained coma after convulsions warrants continuous EEG to exclude non-convulsive status
- Target burst suppression and maintain for 24-48 h before weaning the anaesthetic
- Hunt relentlessly for the cause in super-refractory status, including autoimmune encephalitis
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.